- May 6, 2020
-
Areva Pharmaceuticals would like to announce the addition of Irinotecan HCL Injection 300mg/15ml to our existing Irinotecan family that includes 40mg/2ml and 100mg/5ml.
- May 6, 2020
-
Areva Pharmaceuticals is excited to announce three new products to our ever-expanding portfolio:
- March 6, 2019
-
Areva Pharmaceuticals is excited to announce another addition to our growing product portfolio – Temozolomide (oral capsule)
- AUGUST 1, 2018
-
Pamidronate Disodium now available.
- JULY 27, 2015
-
Ernst & Young announces Areva Pharmaceuticals Founder & CEO Victor Swaminathan as an EY Entrepreneur Of The Year® 2015 Award finalist in Ohio Valley
- DECEMBER 19, 2014
-
Areva Pharmaceuticals was granted VAWD accreditation by NABP (National Association of Boards of Pharmacy)
- JULY 2014
-
Areva Pharmaceuticals was pleased to announce it was awarded contracts by Amerinet for Irinotecan and Pamidronate.
- MAY 16, 2014
-
Areva Pharmaceuticals owners and community leaders were joined by residents of the Lanesville Indiana and outlying communities for a ribbon cutting ceremony and open house.
- JUNE 2013
-
Areva Pharmaceuticals was awarded a contract with Apexus for Epirubicin, Irinotecan, and Pamidronate.
- MARCH 5, 2013
-
Local Community Rolls Out Red Carpet for Areva
- OCTOBER 21, 2010
-
Areva receives FDA approval for Pamidronate Disodium Injection 3 mg/ml and 9 mg/ml
Areva Gallery
